NDC Package 66112-914-04 Glipizide

Tablet - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

66112-914-04

Package Description:

18000 TABLET in 1 BOTTLE

Product Code:

66112-914

Non-Proprietary Name:

Glipizide

Substance Name:

Glipizide

Usage Information:

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

11-Digit NDC Billing Format:

66112091404

Product Type:

Drug For Further Processing

Labeler Name:

Piramal Pharma Limited

Dosage Form:

Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.

Active Ingredient(s):

GLIPIZIDE 5 mg/1

Sample Package:

N/A

Marketing Category:

DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.

Start Marketing Date:

05-01-2017

Listing Expiration Date:

12-31-2026

Exclude Flag:

Unfinished Product:

Yes

Code Structure:

66112 - Piramal Pharma Limited
- 66112-914 -
  - 66112-914-04 - 18000 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
66112-914-01	100 TABLET in 1 BOTTLE
66112-914-02	500 TABLET in 1 BOTTLE
66112-914-03	1000 TABLET in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 66112-914-04?

The NDC Packaged Code 66112-914-04 is assigned to an UNFINISHED drug package of 18000 tablet in 1 bottle of Glipizide, drug for further processing labeled by Piramal Pharma Limited. The product's dosage form is tablet and is administered via form.

Is NDC 66112-914 included in the NDC Directory?

Yes, Glipizide is an UNFINISHED PRODUCT with code 66112-914 that is active and included in the NDC Directory. The product was first marketed by Piramal Pharma Limited on May 01, 2017 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 66112-914-04?

The 11-digit format is 66112091404. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	66112-914-04	5-4-2	66112-0914-04

Table of Contents